{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:08:03Z","timestamp":1791745683092,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072821"],"award-info":[{"award-number":["82072821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mechanisms underlying lung metastases in bladder cancer (BLCA) remain poorly understood. Cancer-associated fibroblasts (CAFs) are key modulators of the metastatic microenvironment, but how they are activated and contribute to BLCA lung metastases remains unclear. Single-nucleus RNA sequencing was conducted on metastatic lung lesions from patients with BLCA to characterize the tumor microenvironment. Functional and molecular biology experiments, including co-culture assays, luciferase reporter assays, chromatin immunoprecipitation and in vivo lung metastasis models, were performed to explore the mechanisms by which tumor-derived factors and CAFs-secreted exosomes contribute to metastasis. The results revealed that CAFs were enriched in metastatic lung lesions and activated by tumor-derived WNT7A via the Wnt\/\u03b2-catenin pathway. These activated CAFs promoted BLCA cell proliferation, stemness and migration through the exosomal delivery of miR-1910-5p, which directly suppressed CTDNEP1 expression and activated MYC signaling. Mechanistically, RBMX was identified as a regulator of miR-1910-5p packaging into CAFs-derived exosomes. In vivo, inhibition of CAFs-derived exosomes secretion reduced lung metastasis, highlighting their critical role in metastasis formation. In conclusion, this study uncovers a novel reciprocal activation loop between tumor cells and CAFs in BLCA lung metastases, where tumor-secreted WNT7A activates resident pulmonary CAFs, which in turn enhance tumor malignancy through exosomal delivery of miR-1910-5p. This exosome-mediated crosstalk promotes metastatic progression via the CTDNEP1\/MYC signaling pathway. These findings provide potential therapeutic targets for mitigating metastatic progression in BLCA.<\/jats:p>","DOI":"10.1038\/s12276-026-01735-x","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:21:11Z","timestamp":1780471271000},"page":"1806-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-derived WNT7A reprograms pulmonary fibroblasts to remodel the metastatic niche and promote bladder cancer lung metastasis"],"prefix":"10.1038","volume":"58","author":[{"given":"Zhengnan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denglong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"1735_CR1","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes, J. et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur. Urol. 71, 462\u2013475 (2017).","journal-title":"Eur. Urol."},{"key":"1735_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur. Urol. 71, 96\u2013108 (2017).","journal-title":"Eur. Urol."},{"key":"1735_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massagu\u00e9","year":"2016","unstructured":"Massagu\u00e9, J. & Obenauf, A. C. Metastatic colonization by circulating tumour cells. Nature 529, 298\u2013306 (2016).","journal-title":"Nature"},{"key":"1735_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson, T., Batlle, E. & Massagu\u00e9, J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell 14, 306\u2013321 (2014).","journal-title":"Cell Stem Cell"},{"key":"1735_CR5","doi-asserted-by":"publisher","first-page":"114504","DOI":"10.1016\/j.addr.2022.114504","volume":"189","author":"R Rimal","year":"2022","unstructured":"Rimal, R. et al. Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting. Adv. Drug Deliv. Rev. 189, 114504 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1735_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1101-4","volume":"18","author":"J Kong","year":"2019","unstructured":"Kong, J. et al. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts. Mol. Cancer 18, 175 (2019).","journal-title":"Mol. Cancer"},{"key":"1735_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat. Commun. 9, 191 (2018).","journal-title":"Nat. Commun."},{"key":"1735_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri, L. et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer 18, 75 (2019).","journal-title":"Mol. Cancer"},{"key":"1735_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jconrel.2015.06.029","volume":"219","author":"L Milane","year":"2015","unstructured":"Milane, L., Singh, A., Mattheolabakis, G., Suresh, M. & Amiji, M. M. Exosome mediated communication within the tumor microenvironment. J. Control. Release 219, 278\u2013294 (2015).","journal-title":"J. Control. Release"},{"key":"1735_CR10","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977(2020)."},{"key":"1735_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.01.004","volume":"67","author":"RJ Lobb","year":"2017","unstructured":"Lobb, R. J., Lima, L. G. & M\u00f6ller, A. Exosomes: key mediators of metastasis and pre-metastatic niche formation. Semin. Cell Dev. Biol. 67, 3\u201310 (2017).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1735_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","volume":"5","author":"J Dai","year":"2020","unstructured":"Dai, J. et al. Exosomes: key players in cancer and potential therapeutic strategy. Signal Transduct. Target. Ther. 5, 145 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1735_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang, J. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13, 17\u201324 (2015).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1735_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0897-7","volume":"17","author":"Z Sun","year":"2018","unstructured":"Sun, Z. et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol. Cancer 17, 147 (2018).","journal-title":"Mol. Cancer"},{"key":"1735_CR15","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1016\/j.cell.2023.09.021","volume":"186","author":"X Qi","year":"2023","unstructured":"Qi, X. et al. Molecular basis of Wnt biogenesis, secretion, and Wnt7-specific signaling. Cell 186, 5028\u20135040 (2023).","journal-title":"Cell"},{"key":"1735_CR16","first-page":"895","volume":"21","author":"H Kirikoshi","year":"2002","unstructured":"Kirikoshi, H. & Katoh, M. Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. Int. J. Oncol. 21, 895\u2013900 (2002).","journal-title":"Int. J. Oncol."},{"key":"1735_CR17","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1074\/jbc.RA118.001689","volume":"293","author":"X Huang","year":"2018","unstructured":"Huang, X. et al. Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p. J. Biol. Chem. 293, 6693\u20136706 (2018).","journal-title":"J. Biol. Chem."},{"key":"1735_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","volume":"595","author":"JC Melms","year":"2021","unstructured":"Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"1735_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392\u2013401 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1735_CR20","first-page":"147","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G. & Tuveson, D. A. Diversity and biology of cancer-associated fibroblasts. Phys. Rev. 101, 147\u2013176 (2021).","journal-title":"Phys. Rev."},{"key":"1735_CR21","doi-asserted-by":"crossref","unstructured":"Cadigan, K. M. & Waterman, M. L. TCF\/LEFs and Wnt signaling in the nucleus. Cold Spring Harb. Perspect. Biol. 4, a007906(2012).","DOI":"10.1101\/cshperspect.a007906"},{"key":"1735_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569\u2013579 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1735_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"1735_CR24","doi-asserted-by":"publisher","first-page":"D301","DOI":"10.1093\/nar\/gkq1069","volume":"39","author":"KB Cook","year":"2011","unstructured":"Cook, K. B., Kazan, H., Zuberi, K., Morris, Q. & Hughes, T. R. RBPDB: a database of RNA-binding specificities. Nucleic Acids Res. 39, D301\u2013D308 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1735_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36400-8","volume":"14","author":"Z Luo","year":"2023","unstructured":"Luo, Z. et al. Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability. Nat. Commun. 14, 762 (2023).","journal-title":"Nat. Commun."},{"key":"1735_CR26","doi-asserted-by":"crossref","unstructured":"The global challenge of cancer. Nat. Cancer 1, 1\u20132 (2020).","DOI":"10.1038\/s43018-019-0023-9"},{"key":"1735_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target. Ther. 5, 28 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1735_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"1735_CR29","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.pharmthera.2023.108522","volume":"250","author":"SU Khan","year":"2023","unstructured":"Khan, S. U., Fatima, K., Malik, F., Kalkavan, H. & Wani, A. Cancer metastasis: molecular mechanisms and clinical perspectives. Pharmacol. Ther. 250, 108522 (2023).","journal-title":"Pharmacol. Ther."},{"key":"1735_CR30","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nrc2622","volume":"9","author":"DX Nguyen","year":"2009","unstructured":"Nguyen, D. X., Bos, P. D. & Massagu\u00e9, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 9, 274\u2013284 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1735_CR31","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrc2621","volume":"9","author":"B Psaila","year":"2009","unstructured":"Psaila, B. & Lyden, D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 9, 285\u2013293 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1735_CR32","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41556-018-0145-9","volume":"20","author":"T Celi\u00e0-Terrassa","year":"2018","unstructured":"Celi\u00e0-Terrassa, T. & Kang, Y. Metastatic niche functions and therapeutic opportunities. Nat. Cell Biol. 20, 868\u2013877 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1735_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1735_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582\u2013598 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1735_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","volume":"17","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J. Hematol. Oncol. 17, 80 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"1735_CR36","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct. Target. Ther. 6, 218 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1735_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.canlet.2018.10.015","volume":"442","author":"S Wen","year":"2019","unstructured":"Wen, S. et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23-p38 MAPK signalling. Cancer Lett. 442, 320\u2013332 (2019).","journal-title":"Cancer Lett."},{"key":"1735_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/cac2.12414","volume":"43","author":"JW Eun","year":"2023","unstructured":"Eun, J. W. et al. Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Commun. 43, 455\u2013479 (2023).","journal-title":"Cancer Commun."},{"key":"1735_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis. Cell Death Dis. 13, 478 (2022).","journal-title":"Cell Death Dis."},{"key":"1735_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li, C., Teixeira, A. F., Zhu, H. J. & Ten Dijke, P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol. Cancer 20, 154 (2021).","journal-title":"Mol. Cancer"},{"key":"1735_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.795372","volume":"12","author":"L Peng","year":"2021","unstructured":"Peng, L. et al. Emerging role of cancer-associated fibroblasts-derived exosomes in tumorigenesis. Front. Immunol. 12, 795372 (2021).","journal-title":"Front. Immunol."},{"key":"1735_CR42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100294RR","volume":"35","author":"B Li","year":"2021","unstructured":"Li, B., Cao, Y., Sun, M. & Feng, H. Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. FASEB J. 35, e21916 (2021).","journal-title":"FASEB J."},{"key":"1735_CR43","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/thno.53412","volume":"11","author":"B Chen","year":"2021","unstructured":"Chen, B. et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics 11, 3932\u20133947 (2021).","journal-title":"Theranostics"},{"key":"1735_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer 19, 43 (2020).","journal-title":"Mol. Cancer"},{"key":"1735_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.989","volume":"12","author":"L Shi","year":"2022","unstructured":"Shi, L. et al. Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. Clin. Transl. Med. 12, e989 (2022).","journal-title":"Clin. Transl. Med."},{"key":"1735_CR46","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","volume":"83","author":"J Zhuang","year":"2023","unstructured":"Zhuang, J. et al. Cancer-associated fibroblast-derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance. Cancer Res. 83, 1611\u20131627 (2023).","journal-title":"Cancer Res."},{"key":"1735_CR47","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1111\/cas.15067","volume":"112","author":"W Panvongsa","year":"2021","unstructured":"Panvongsa, W. et al. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma. Cancer Sci. 112, 4257\u20134269 (2021).","journal-title":"Cancer Sci."},{"key":"1735_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri, C. et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat. Commun. 4, 2980 (2013).","journal-title":"Nat. Commun."},{"key":"1735_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1604-0","volume":"20","author":"X Qin","year":"2019","unstructured":"Qin, X. et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5. Genome Biol. 20, 12 (2019).","journal-title":"Genome Biol."},{"key":"1735_CR50","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","volume":"17","author":"L Santangelo","year":"2016","unstructured":"Santangelo, L. et al. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting. Cell Rep. 17, 799\u2013808 (2016).","journal-title":"Cell Rep."},{"key":"1735_CR51","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41419-021-04409-w","volume":"12","author":"Z Yan","year":"2021","unstructured":"Yan, Z. et al. Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Cell Death Dis. 12, 1120 (2021).","journal-title":"Cell Death Dis."},{"key":"1735_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-357","volume":"13","author":"J Guduric-Fuchs","year":"2012","unstructured":"Guduric-Fuchs, J. et al. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics 13, 357 (2012).","journal-title":"BMC Genomics"},{"key":"1735_CR53","doi-asserted-by":"crossref","unstructured":"Shurtleff, M. J., Temoche-Diaz, M. M., Karfilis, K. V., Ri, S. & Schekman, R. Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction. eLife 5, e19276(2016).","DOI":"10.7554\/eLife.19276"},{"key":"1735_CR54","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1073\/pnas.0702099104","volume":"104","author":"Y Kim","year":"2007","unstructured":"Kim, Y. et al. A conserved phosphatase cascade that regulates nuclear membrane biogenesis. Proc. Natl Acad. Sci. USA 104, 6596\u20136601 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1735_CR55","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1016\/j.devcel.2021.11.009","volume":"56","author":"H Merta","year":"2021","unstructured":"Merta, H. et al. Cell cycle regulation of ER membrane biogenesis protects against chromosome missegregation. Dev. Cell 56, 3364\u20133379 (2021).","journal-title":"Dev. Cell"},{"key":"1735_CR56","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cub.2021.01.007","volume":"31","author":"FJ Calero-Cuenca","year":"2021","unstructured":"Calero-Cuenca, F. J. et al. Ctdnep1 and Eps8L2 regulate dorsal actin cables for nuclear positioning during cell migration. Curr. Biol. 31, 1521\u20131530 (2021).","journal-title":"Curr. Biol."},{"key":"1735_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150063","volume":"719","author":"T Konno","year":"2024","unstructured":"Konno, T. et al. Ctdnep1 phosphatase is required for negative regulation of RANKL-induced osteoclast differentiation in RAW264.7 cells. Biochem. Biophys. Res. Commun. 719, 150063 (2024).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01735-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01735-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01735-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:34:37Z","timestamp":1782909277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01735-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1735"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01735-x","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was reviewed and approved by the Ethical Committee of the Shanghai General Hospital. Animal experiments were performed in accordance with protocols approved by the Ethics Committees of Shanghai General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}